Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
Wilhelm Kriz, … , Brigitte Kaissling, Michel Le Hir
Wilhelm Kriz, … , Brigitte Kaissling, Michel Le Hir
Published February 1, 2011
Citation Information: J Clin Invest. 2011;121(2):468-474. https://doi.org/10.1172/JCI44595.
View: Text | PDF
Personal perspective

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

  • Text
  • PDF
Abstract

Epithelial-mesenchymal transition (EMT) has become widely accepted as a mechanism by which injured renal tubular cells transform into mesenchymal cells that contribute to the development of fibrosis in chronic renal failure. However, an increasing number of studies raise doubts about the existence of this process in vivo. Herein, we review and summarize both sides of this debate, but it is our view that unequivocal evidence supporting EMT as an in vivo process in kidney fibrosis is lacking.

Authors

Wilhelm Kriz, Brigitte Kaissling, Michel Le Hir

×

Figure 1

In the kidney, FSP1/S100A4 does not stain fibroblasts or myofibroblast.

Options: View larger image (or click on image) Download as PowerPoint
In the kidney, FSP1/S100A4 does not stain fibroblasts or myofibroblast.
...
(A) Double immunofluorescence for S100A4 (red channel) and ecto-5′nucleotidase (5′NT, green channel) and (B) for S100A4 (red channel) and α-SMA (green channel); nuclei in B are stained by DAPI. (A) 3-mm-thick cryostat section of renal cortex (rat); the thick arrow points to a 5′NT-positive interstitial fibroblast; S100A4-positive cells (thin arrows) are seen inside capillaries. Scale bar: ~10 mm. Reproduced with permission from Histochemistry and Cell Biology (15). (B) Renal cortex after 4 days of ureteral obstruction (rat); no cellular colocalization of S100A4 and α-SMA. G, glomerulus. Inset: S100A4-positive cells, showing strong cytoplasmic and weak nuclear staining; the shape of the cells is reminiscent of migrating lymphocytes. Scale bars: ~100 mm; inset, ~10 mm. Reproduced with permission from Histochemistry and Cell Biology (17).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts